Financhill
Back

Enliven Therapeutics Quote, Financials, Valuation and Earnings

Enliven Therapeutics Price Quote

$24.13
+0.05 (+1.43%)
(Updated: December 12, 2024 at 2:38 AM ET)

Enliven Therapeutics Key Stats

Sell
29
Enliven Therapeutics (ELVN) is a Sell

Day range:
$23.10 - $24.31
52-week range:
$9.80 - $30.03
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.03%

Volume:
196.7K
Avg. volume:
219.9K
1-year change:
121.53%
Market cap:
$1.2B
Revenue:
$0
EPS:
$-1.89

How Much Does Enliven Therapeutics Make?

Data Unavailable

Is Enliven Therapeutics Growing As A Company?

Data Unavailable

Enliven Therapeutics Stock Price Performance

What Is Enliven Therapeutics 52-Week High & Low?

Enliven Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Enliven Therapeutics?

Is Enliven Therapeutics Cash Flow Positive?

  • What Is ELVN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$68.5M
  • What Is Enliven Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $93.3M
  • What Is Enliven Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $2M

Enliven Therapeutics Return On Invested Capital

Data Unavailable

Enliven Therapeutics Earnings Date & Stock Price

Enliven Therapeutics Competitors

Enliven Therapeutics Dividend Yield

Enliven Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 4.36%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 37.17
Upside from Last Price: 54.35%

Major Shareholders

  • How many ELVN shares are owned by institutional investors?
    71.7M ELVN shares are owned by institutional investors
  • How many ELVN shares are owned by insiders?
    248.1K ELVN shares are owned by insiders